[6-years' experience with the clinical use of the hemostatic preparation, PPSB].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D002648:Child; D004844:Epistaxis / Q000628:therapy; D005164:Factor IX / Q000627:therapeutic use; D005167:Factor VII / Q000627:therapeutic use; D005170:Factor X / Q000627:therapeutic use; D005260:Female; D006467:Hemophilia A / Q000628:therapy; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008595:Menorrhagia / Q000628:therapy; D008875:Middle Aged; D011516:Prothrombin / Q000627:therapeutic use
D001779:Blood Coagulation Factors; D006490:Hemostatics; D005167:Factor VII; D011516:Prothrombin; D005164:Factor IX; D005170:Factor X
Shestiletniĭ opyt klinicheskogo primeneniia gemostaticheskogo preparata PPSB.